New advancements in artificial intelligence have the capacity to deliver major breakthroughs in cancer therapy.
AI-powered protein design company Profluent used AI to make an open-source gene editor called OpenCRISPR-1.
OpenCRISPR-1 ...
Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.
To read of AI’s feats in ...
Much as ChatGPT generates poetry, a new A.I. system devises blueprints for microscopic mechanisms that can edit your DNA.
Generative A.I. technologies can write poetry and computer programs or create images of teddy ...
The most striking evidence that artificial intelligence can provide profound scientific breakthroughs came with the unveiling of a program called AlphaFold by Google DeepMind.
In 2016 researchers at the company ...
As OpenAI's CEO, Altman is widely considered to be the face of artificial intelligence, reprogramming the way we'll live and work for years to come. His relentless push into ...
Funding propels company’s proprietary platform consisting of Generative AI models and large-scale datasets purpose-built for designing and validating novel proteins, opening new frontiers in therapeutics and industrial applications
...
Venture capitalists are financing drugmakers seeking to improve upon today’s blockbuster weight-loss medications or combat their side effects.
New obesity medications have helped millions of people lose weight but can ...
BioAge Labs has reeled in the biotech industry’s largest private financing round so far in 2024 as the California startup goes full throttle on the hottest areas in obesity ...
Funding to advance Phase 2 clinical trials of azelaprag, an apelin receptor (APJ) agonist, in combination with Lilly’s Zepbound (tirzepatide) and therapeutic pipeline
Azelaprag improves metabolic and muscle ...
Joe Betts-LaCroix didn’t have time to wait for architects, construction workers or really any of the normal things that go into building a new office, let alone a new ...
Inceptive’s Jakob Uszkoreit, a pioneer of the technology behind ChatGPT, attracts Nvidia funding to design ‘biological software’.
A biotech start-up founded by a former Google artificial intelligence expert has raised ...
Jakob Uszkoreit, one of the people who laid the groundwork for generative platforms such as ChatGPT, has secured $100 million in a Series A raise for an AI biotech ...
Chronic diseases like cancer, heart disease and diabetes, first hit the average American in their 60s. Cancer is usually diagnosed at 66, the average age for a first heart attack in ...
The Atlantic celebrates science, tech, and a culture of curiosity.
Join us to explore how innovation borrows from unexpected corners, featuring Airbnb’s Brian Chesky, Google DeepMind’s Pushmeet Kohli, Anthropic’s Dario ...
The best use for generative A.I. in health care, doctors say, is to ease the heavy burden of documentation that takes them hours a day and contributes to burnout.
From ...
Over 1,000 times a day, distressed people call crisis support lines operated by Protocall Services. Its counselors are carefully trained for the sensitive and taxing conversations, but even with ...
Health care
I spoke with Nikhil Buduma and Mike Ng, the cofounders of Ambience Health, which is funded by OpenAI.
The startup uses GPT-4 to generate medical documentation based on provider-patient ...
When a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million to bankroll an audacious mission: to add 10 years to ...
As a postdoctoral researcher at Stanford University, Kristen Fortney used bioinformatics to study the genetics of supercentenarians — people who live to the age of 110 and beyond. Now ...
Ambience Healthcare's new product, AutoScribe, embeds into the electronic medical record and works in real-time. When clinicians use AutoScribe, they speak to their patient as they normally would while ...
We sat down with some of the most curious minds in life sciences and healthcare and invited them to share their thoughts on their careers, the future of health ...
BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced positive Phase 1b clinical data ...
Brightseed Bio 01™ is the first ingredient in Brightseed’s portfolio of bioactives discovered by its artificial intelligence (A.I.) platform Forager®
Formulated to optimize bioactives that support gut health, ...
